Clinical Trial Update: Safety of IFNa Kinoid in Systemic Lupus Erythematosus [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on the safety of IFNa Kinoid in systemic lupus erythematosus, completed phases 1 and 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• IFNa Kinoid

Snippet

Sponsor: Neovacs | Conditions: Systemic Lupus Erythematosus | Phase 1, Phase 2 | Status: COMPLETED